Galaxy Surfactants relentless focus on expanding the high-margin specialty care product segment, currently fetching ~40% of revenues, is expected to drive an Ebitda CAGR of ~14.3% over the span FY24-27.
Beakers containing beer sit on a table in a laboratory. (Photo: Dragos Condrea/ freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.